BioAmber Inc. · Transaction Jun 9, 2016 · Filed Jul 13, 2016 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · BIOA
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
BIOAGE Labs Inc
Pharmaceuticals
$6.21
Follow $BIOA
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $BIOA by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredThu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET · BIOA
MethodologyBIOA
BIOAGE Labs Inc
Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Lower range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
38/ 100
Veridion Score
Lower range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BIOA moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BIOAGE Labs Inc
PHARMACEUTICAL PREPARATIONSListed since
2024
Employees
62
Country
US
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$6.21
Last session
Day high
$6.21
Last session
Day low
$6.21
Last session
Previous close
$6.21
52W high
$25.10
-75.26% from high
52W low
$5.11
6% of range
Market cap
$285M
EPS
$-2.3854
Beta
1.44
Shares out
45.9M
Avg volume
784.7K
VWAP
$6.21
Last session
Price history computed in-house
1W
-6.05%
1M
-32.28%
3M
-74.49%
1Y
+13.94%
YTD
-53.06%
SMA 50 $9.32 · below
SMA 200 $16.58 · below
52W position 6%
BIOA overview
Related filings and maps
Public disclosures
Congress activity in BIOA
1 filers · 3 buys · 1 sells (0 labeled S (partial)) · Jul 24, 2014 to Jun 9, 2016 · House 4 / Senate 0
All available history · Latest 4 of 4 lines · Read 2026-10-09T08:49:31.641Z
Official filing ↗
Bioamber Inc. · Transaction Oct 10, 2014 · Filed Nov 20, 2014 · $1,001 to $15,000
Bioamber Inc. · Transaction Oct 9, 2014 · Filed Nov 20, 2014 · $1,001 to $15,000
Bioamber Inc. · Transaction Jul 24, 2014 · Filed Aug 17, 2014 · $15,001 to $50,000
Federal contracts
BIOA contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BIOA in this window.
Lobbying spend
BIOA lobbying filings, year to date.
Registered lobbying filings matched to BIOAGE Labs Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BIOA in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BIOA.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.